𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma : Carboplatin and gemcitabine followed by paclitaxel

✍ Scribed by Javier De Castro; Jamie Feliu; Enrique Casado; Amalio Ordonñez; Manuel González Barón

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
69 KB
Volume
94
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential combination chemotherapy in p
Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma : Carboplatin and gemcitabine followed by paclitaxel
✍ Martin J. Edelman; David R. Gandara; Derrick H. M. Lau; Primo Lara; I. Jun Laude 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Background: The objective of this phase ii study was to evaluate the concept of sequential chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma (nsclc) by the administration of carboplatin plus gemcitabine followed by of paclitaxel. ## Methods: Patients with sta

Sequential chemotherapy in nonsmall-cell
Sequential chemotherapy in nonsmall-cell lung cancer : Cisplatin and gemcitabine followed by docetaxel
✍ Anna Ceribelli; Maria S. Pino; Alain J. Gelibter; Michele Milella; Fabiana L. Ce 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

## Abstract ## BACKGROUND. Improving results in nonsmall‐cell lung cancer (NSCLC) will require the development of new drugs and strategies to combine available agents. On the basis of data indicating the activity of docetaxel as second‐line therapy, a Phase II study was conducted to evaluate the e

Phase I/II trial of paclitaxel by 1-hour
Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma
✍ John D. Hainsworth; Howard A. Burris III; Joan B. Erland; Lisa H. Morrissey; Ant 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

## BACKGROUND. The combination of paclitaxel and carboplatin is widely used in the treatment of patients with advanced nonsmall cell lung carcinoma. In this Phase I/II study the authors evaluated the feasibility, toxicity, and efficacy of adding a third active antineoplastic agent, gemcitabine, to

A Phase II trial of gemcitabine and doce
A Phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma
✍ Irina E. Popa; Kathleen Stewart; Frederick P. Smith; Naiyer A. Rizvi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

## Abstract ## BACKGROUND The goals of the current study were to determine the safety and efficacy of a nonplatinum‐containing doublet, gemcitabine and docetaxel, in the treatment of patients with chemotherapy‐naive nonsmall cell lung carcinoma (NSCLC). ## METHODS Thirty‐two patients with advanc